Press release content from Business Wire. The AP news staff was not involved in its creation. Genus plc Provides Update on Financial Performance for First Half of Fiscal 2021 January 18, 2021 GMT BASINGSTOKE, England & MADISON, Wis.--(BUSINESS WIRE)--Jan 18, 2021-- Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported continued strong performance across its operations for the six-months period ending December 31, 2020. The strong trading performance reported by the Company at its recent Annual General Meeting (AGM) on November 25, 2020 has continued through the first half of Genus’s financial year, and the adjusted profit before tax of the Group in actual currency is now expected to be within a range of £47.0m and £49.0m for the first half (six months to December 31, 2019: £36.6m). Revenue for the period is now expected to be within a range of £285.0m to £287.0m (six months to December 31, 2019: £270.7m). High growth in volumes, revenue and adjusted operating profit were achieved across the Groups’ operations by both PIC and ABS, our porcine and bovine genetics businesses respectively. Business trends are consistent with those previously announced at the time of the AGM, including further strong growth achieved, in particular, by PIC in China and by ABS in Brazil, Russia, India and China.